Clearstead Advisors, LLC Rocket Pharmaceuticals, Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 726 shares of RCKT stock, worth $2,366. This represents 0.0% of its overall portfolio holdings.
Number of Shares
726Holding current value
$2,366% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
95.7MCall Options Held
587KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$57.7 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$27.3 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.89MShares$22.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$20.2 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.14MShares$13.5 Million0.35% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $247M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...